China’s Demand for Heparin Will Continue to Grow at 12% by 2024 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 10, 2018--The “Heparin Markets in China” report has been added to ResearchAndMarkets.com’s offering.
China’s demand for Heparin has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China’s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2007, 2012 and 2017) and long-term forecasts through 2022 and 2027 are presented. Major producers in China are profiled.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.
Key Topics Covered:
II. BUSINESS ENVIRONMENT
III. HEPARIN INDUSTRY ASSESSMENTS
IV. HEPARIN SALES VOLUMES AND FORECASTS
V. HEPARIN MARKET OUTLOOKS
VI. MARKETING STRATEGIES
VII. HEPARIN PRODUCER DIRECTORY
Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
Shanghai Roche Pharmacy Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/d2hqrr/chinas_demand?w=4
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180710005456/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Drugs
KEYWORD: ASIA PACIFIC CHINA
INDUSTRY KEYWORD: HEALTH CARDIOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/10/2018 06:11 AM/DISC: 07/10/2018 06:11 AM